---
title: "Evolus wins approval for hyaluronic acid dermal fillers"
date: "2025-02-13 22:05:20"
summary: "The U.S. FDA granted approval to Evolus' (NASDAQ:EOLS) Evolysse Form and Smooth hyaluronic gels. The company plans to launch the products in Q2. \"The launch of these products is a catalyst in our growth as we are focused on achieving at least $700 million in net revenue and non-GAAP operating..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1555306451/image_1555306451.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* The U.S. FDA granted approval to Evolus' (NASDAQ:[EOLS](https://seekingalpha.com/symbol/EOLS "Evolus, Inc.")) Evolysse Form and Smooth hyaluronic gels.
* The company plans to launch the products in Q2.
* "The launch of these products is a catalyst in our growth as we are focused on achieving at least $700 million in net revenue and non-GAAP operating income margin of at least 20% by 2028," CEO David Moatazedi said in a [news release](https://seekingalpha.com/pr/20002166-evolus-announces-fda-approval-of-evolysse-form-and-evolysse-smooth-injectable-hyaluronic-acid "news release").

[seekalpha](https://seekingalpha.com/news/4408009-evolus-wins-approval-hyaluronic-acid-dermal-fillers)
